Mei'an Pharmaceutical signed an agreement with RDbiomd UK

Publisher:Maxhealth  DATE:2017/4/30

In April 2017, the company signed an agreement with Peptest, a research and development and production company of gastroesophageal reflux diagnostic reagent, RDbiomd, UK, to acquire a 20.51% stake in the company by subscribing for its new and old shares.